EUVIMEDEUVIMED entdecken
Crossref

Insights into the structure-activity relationship of pyrimidine-sulfonamide analogues for targeting BRAF V600E protein

Tarapong Srisongkram, Dheerapat Tookkane

Biophysical Chemistry · 2024

DOI: 10.1016/j.bpc.2024.107179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biophysical Chemistry, 2024. Verfasst von Tarapong Srisongkram und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, 40002, Thailand. Electronic address: tarasri@kku.ac.t…. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Research Council of Thailand, Khon Kaen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B-rapidly accelerated fibrosarcoma (BRAF) V600E plays a crucial role in the progression of cutaneous melanoma. Core structures of BRAF V600E inhibitors are based on pyrimidine-sulfonamide scaffolds. Exploring the QSAR of these structures can improve our understanding of BRAF V600E inhibitor drug design. This study utilized machine learning-based QSAR to elucidate chemical substructures of pyrimidine-sulfonamide analogues that correlated to the BRAF V600E inhibitory activity. The findings indicate that the support vector regression (SVR) combined with 15 fingerprints achieved the highest statistical performances in terms of goodness-of-fit, robustness, and predictability. Nine key fingerprints from pyrimidine-sulfonamide analogues were identified to exert the BRAF V600E inhibitory activity. These key fingerprints were validated using network-based activity cliff landscape and molecular docking. Together, the developed algorithm can serve as a screening tool for designing BRAF V600E inhibitors. To further utilize this model, we deployed our developed algorithm at https://qsarlabs.com/#braf.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsHumansProto-Oncogene Proteins B-rafMolecular Docking SimulationCell ProliferationStructure-Activity RelationshipSulfonamidesPyrimidinesProtein Kinase InhibitorsMutationCell Line, Tumor

Stichwörter der Autor:innen

Activity cliffBRAF V600EMachine learningPyrimidine-sulfonamideStructure-activity relationship

Substanzen

Proto-Oncogene Proteins B-rafSulfonamidesPyrimidinesProtein Kinase InhibitorsBRAF protein, human

Autor:innen und Institutionen

  • Division of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, 40002, Thailand. Electronic address: tarasri@kku.ac.th.
  • Division of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, 40002, Thailand.

Förderung

  • National Research Council of Thailand
  • Khon Kaen University

Zitieren

APA

Srisongkram, T., & Tookkane, D. (2024). Insights into the structure-activity relationship of pyrimidine-sulfonamide analogues for targeting BRAF V600E protein. Biophysical Chemistry. https://doi.org/10.1016/j.bpc.2024.107179

Vancouver

Srisongkram T, Tookkane D. Insights into the structure-activity relationship of pyrimidine-sulfonamide analogues for targeting BRAF V600E protein. Biophysical Chemistry. 2024. doi:10.1016/j.bpc.2024.107179

BibTeX
@article{Srisongkram2024,
  author = {Srisongkram, Tarapong and Tookkane, Dheerapat},
  title = {Insights into the structure-activity relationship of pyrimidine-sulfonamide analogues for targeting BRAF V600E protein},
  journal = {Biophysical Chemistry},
  year = {2024},
  doi = {10.1016/j.bpc.2024.107179}
}
Kostenlos starten →